MedTrace Logo

Enhancing Slow Wave Sleep With Sodium Oxybate

NCT00506974 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-09-26

No results posted yet for this study

Summary

The purpose of this study is to determine if there the impact of sleep deprivation upon sleepiness, attention, memory, and mood is reduced by pharmacologically enhancing slow wave sleep (SWS) with sodium oxybate.

Conditions

  • Sleep

Interventions

DRUG

sodium oxybate

3.5 g of sodium oxybate or placebo on two of the five overnights.

Sponsors & Collaborators

Principal Investigators

  • James K Walsh, Ph.D. · Sleep Medicine and Research Center at St. Luke's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00506974 on ClinicalTrials.gov